Treatment duration of immune checkpoint inhibitors and overall survival in U.S. veterans with Cancer
Journal of Oncology Pharmacy Practice
Published online on July 11, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
BackgroundOptimal treatment duration for immune checkpoint inhibitors (ICI) remains a clinical debate. The objective of this study was to contrast mortality rates between 2-year fixed versus indefinite treatment duration among patients initiating ICIs ...
BackgroundOptimal treatment duration for immune checkpoint inhibitors (ICI) remains a clinical debate. The objective of this study was to contrast mortality rates between 2-year fixed versus indefinite treatment duration among patients initiating ICIs ...